MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41419-024-07096-5

Медицинская библиотека · Cell death & disease · 2024

Altered molecular and cellular mechanisms in KIF5A-associated neurodegenerative or neurodevelopmental disorders.

Cozzi Marta, Magri Stefania, Tedesco Barbara, Patelli Guglielmo, Ferrari Veronica, Casarotto Elena, Chierichetti Marta, Pramaggiore Paola, Cornaggia Laura, Piccolella Margherita, Galbiati Mariarita, Rusmini Paola, Crippa Valeria, Mandrioli Jessica, Pareyson Davide, Pisciotta Chiara, D'Arrigo Stefano, Ratti Antonia, Nanetti Lorenzo, Mariotti Caterina, Sarto Elisa, Pensato Viviana, Gellera Cinzia, Di Bella Daniela, Cristofani Riccardo M, Taroni Franco, Poletti Angelo

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Mutations targeting distinct domains of the neuron-specific kinesin KIF5A associate with different neurodegenerative/neurodevelopmental disorders, but the molecular bases of this clinical heterogeneity are unknown. We characterised five key mutants covering the whole spectrum of KIF5A-related phenotypes: spastic paraplegia (SPG, R17Q and R280C), Charcot-Marie-Tooth disease (CMT, R864*), amyotrophic lateral sclerosis (ALS, N999Vfs*40), and neonatal intractable myoclonus (NEIMY, C975Vfs*73) KIF5A mutants. CMT-R864*-KIF5A and ALS-N999Vfs*40-KIF5A showed impaired autoinhibition and peripheral localisation accompanied by altered mitochondrial distribution, suggesting transport competence disruption. ALS-N999Vfs*40-KIF5A formed SQSTM1/p62-positive inclusions sequestering WT-KIF5A, indicating a gain of toxic function. SPG-R17Q-KIF5A and ALS-N999Vfs*40-KIF5A evidenced a shorter half-life compared to WT-KIF5A, and proteasomal blockage determined their accumulation into detergent-insoluble inclusions. Interestingly, SPG-R280C-KIF5A and ALS-N999Vfs*40-KIF5A both competed for degradation with proteasomal substrates. Finally, NEIMY-C975Vfs*73-KIF5A displayed a similar, but more severe aberrant behaviour compared to ALS-N999Vfs*40-KIF5A; these two mutants share an abnormal tail but cause disorders on the opposite end of KIF5A-linked phenotypic spectrum. Thus, our observations support the pathogenicity of novel KIF5A mutants, highlight abnormalities of recurrent variants, and demonstrate that both unique and shared mechanisms underpin KIF5A-related diseases.

Для цитирования: Cozzi Marta, Magri Stefania, Tedesco Barbara, Patelli Guglielmo, Ferrari Veronica, Casarotto Elena, Chierichetti Marta, Pramaggiore Paola, Cornaggia Laura, Piccolella Margherita, Galbiati Mariarita, Rusmini Paola, Crippa Valeria, Mandrioli Jessica, Pareyson Davide, Pisciotta Chiara, D'Arrigo Stefano, Ratti Antonia, Nanetti Lorenzo, Mariotti Caterina, Sarto Elisa, Pensato Viviana, Gellera Cinzia, Di Bella Daniela, Cristofani Riccardo M, Taroni Franco, Poletti Angelo. Altered molecular and cellular mechanisms in KIF5A-associated neurodegenerative or neurodevelopmental disorders.. Cell death & disease. 2024. DOI: 10.1038/s41419-024-07096-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.